Password reminder
Cardiovascular News
Contact the editor Visit Cardiovascular News Twitter feed Visit Cardiovascular News Facebook page

Cardiovascular effects of Japan’s 2011 earthquake and tsunami: Incidence rises with the seismic peak

Tuesday, 28 Aug 2012 16:24

The Japanese earthquake and tsunami of 11 March 2011, which hit the north-east coast of Japan with a magnitude of 9.0 on the Richter scale, was one of the largest ocean-trench earthquakes ever recorded in Japan. The tsunami caused huge damage, including 15,861 dead and 3018 missing persons, and, as of 6 June 2012, 388,783 destroyed homes.

Following an investigation of the ambulance records made by doctors in the Miyagi prefecture, close to the epicentre of the earthquake and where the damage was greatest, cardiologist Hiroaki Shimokawa and colleagues from the Tohoku University Graduate School of Medicine at Sendai, Japan, found that the weekly occurrence of five conditions – heart failure, acute coronary syndrome (including unstable angina and acute myocardial infarction), stroke, cardio-pulmonary arrest and pneumonia – all increased sharply soon after the earthquake occurred.

Such reactions – in acute coronary syndrome, stroke and pulmonary embolism – have been reported before, said Shimokawa, in Japan, China and the USA. However, these studies reported only the short-term occurrence of individual cardiovascular disease events, and the mid-term cardiovascular disease effects of such great earthquakes remain to be elucidated. To this end, the study examined all ambulance transport records in the Miyagi prefecture from 11 February to 30 June for each year from 2008 to 2011 (ie, four weeks before to 16 weeks after 11 March, a total of 124,152 records). Incidence records from before, during and after the earthquake disaster were compared, the aftershocks counted and recorded according to a seismic intensity of 1 or greater.

The number of aftershocks in the Miyagi prefecture was frequent during the six weeks after the earthquake, and the second peak was noted as a large aftershock on 7 April 2011 (magnitude of 7.0). Compared with the previous three years, the significant increases in the occurrence of heart failure and pneumonia were steadily prolonged for more than six weeks after the tsunami struck. On the other hand, the incident increases in stroke and cardio-pulmonary arrest followed the pattern of the first and aftershock seismic peaks. The rapid increases in the occurrence of acute coronary syndromes and cardio-pulmonary arrest was followed by a sharp and significant decline. Interestingly, said Shimokawa, age, sex or residence area did not significantly affect the occurrences of cardiovascular disease during or following the tsunami.

“To the best of our knowledge,” he added, “this is the first report to describe the mid-term course of major cardiovascular events and pneumonia after a great earthquake in a large population. In particular, our findings provide the first evidence that the incidence of heart failure was markedly increased over a long period afterwards.” Prevalence of pneumonia, a well known risk factor for deteriorating heart failure, was significantly increased.

The Tohoku University study also found - as reflected in self-monitoring measurements – that blood pressure was significantly elevated after the earthquake. However, transport disruption following the tsunami interrupted delivery of regular medications, such as antihypertensive or antithrombotic drugs, and this may have contributed to the increased cardiovascular events. There was also an increase in the occurrences of ventricular tachyarrhythmias in patients with implantable cardiac defibrillators.

“Taken together,” said Shimokawa, “we consider that discontinuation of drugs, activated sympathetic nervous system, rising blood pressure, and the increased occurrence of tachyarrhythmia and infections were all involved in the increased occurrence of cardiovascular events after the Great Earthquake of Japan.”

Add New Comment

Most popular

“We all need the strength” to challenge unacceptable behaviour
Thursday, 20 Aug 2015
The editors of Annals of Internal Medicine have called for doctors to confront colleagues who act in a disrespectful manner towards patients after an anonymous essay in the journal highlighted ... “We all need the strength” to challenge unacceptable behaviour

FFRCT significantly reduces the number of invasive tests with no sign of obstructive disease
Tuesday, 01 Sep 2015
The PLATFORM study, which was presented at the ESC, indicates that use of FFRCT is associated with a significant reduction in the number of invasive tests that do not find evidence of obstructive ... FFRCT significantly reduces the number of invasive tests with no sign of obstructive disease

Tuesday, 25 Aug 2015
Medtronic has announced that it has signed a definitive agreement to acquire the company Twelve, which is focused on the development of a transcatheter mitral valve implantation (TMVI) device. Medtronic to buy company that is developing a transcatheter mitral valve implantation device


Rediscovering the transfemoral approach for structural heart interventions
Monday, 14 Sep 2015
Before we abandon “the good old femoral route” completely, the advent of structural heart disease interventions means that we still have a use for the approach. Flavio Ribichini explores the use of ... Rediscovering the transfemoral approach for structural heart interventions

Bifurcation lesions: When a two-stent technique is needed
Tuesday, 18 Aug 2015
The advent of second-generation drug-eluting stents and the associated improved safety and efficacy has meant that the risks of using two stents for bifurcation lesions has significantly decreased. M... Bifurcation lesions: When a two-stent technique is needed


Javier Escaned
Wednesday, 02 Sep 2015
Javier Escaned (head of Section, Interventional Cardiology Unit, Hospital Clinico San Carlos, M... Javier Escaned

Deepak L Bhatt
Tuesday, 09 Jun 2015
Deepak L Bhatt (Executive director of Interventional Cardiovascular Programs, Brigham and Women’s H... Deepak L Bhatt

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions